The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
trans-2-(N-(5-chloro-2-methoxyphenyl)phenylsulfonamido)-N-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)cyclohexyl)acetamide ID: ALA2381947
PubChem CID: 73356483
Max Phase: Preclinical
Molecular Formula: C28H29ClN4O5S
Molecular Weight: 569.08
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Cl)cc1N(CC(=O)N[C@H]1CC[C@H](n2c(=O)[nH]c3ccccc32)CC1)S(=O)(=O)c1ccccc1
Standard InChI: InChI=1S/C28H29ClN4O5S/c1-38-26-16-11-19(29)17-25(26)32(39(36,37)22-7-3-2-4-8-22)18-27(34)30-20-12-14-21(15-13-20)33-24-10-6-5-9-23(24)31-28(33)35/h2-11,16-17,20-21H,12-15,18H2,1H3,(H,30,34)(H,31,35)/t20-,21-
Standard InChI Key: DGMXWRVMCVATCV-MEMLXQNLSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
2.1230 -19.3405 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3399 -18.5438 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5415 -18.7542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1053 -17.8278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9293 -17.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3405 -17.1171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9288 -16.4035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1016 -16.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6942 -17.1188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1675 -18.5451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5798 -19.2607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1642 -19.9714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5758 -20.6864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4026 -20.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8159 -19.9675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4019 -19.2555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6418 -19.9653 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.3384 -19.9685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9230 -20.6823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5813 -17.8305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4071 -17.8315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8209 -17.1168 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8191 -18.5472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6450 -18.5482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0579 -19.2642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8801 -19.2672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2978 -18.5543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8870 -17.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0585 -17.8321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1236 -18.5585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3966 -18.1478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6124 -17.8889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3924 -18.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6076 -19.2204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4303 -20.0219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0368 -20.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8234 -20.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9971 -19.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3600 -17.1025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 2 1 0
2 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
12 18 1 0
18 19 1 0
10 20 1 0
20 21 1 0
21 22 2 0
21 23 1 0
24 23 1 6
24 25 1 0
24 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
27 30 1 1
30 34 1 0
33 31 1 0
31 32 1 0
32 30 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 33 1 0
32 39 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 569.08Molecular Weight (Monoisotopic): 568.1547AlogP: 4.49#Rotatable Bonds: 8Polar Surface Area: 113.50Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.86CX Basic pKa: ┄CX LogP: 4.15CX LogD: 4.15Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.33Np Likeness Score: -1.71
References 1. Bregman H, Chakka N, Guzman-Perez A, Gunaydin H, Gu Y, Huang X, Berry V, Liu J, Teffera Y, Huang L, Egge B, Mullady EL, Schneider S, Andrews PS, Mishra A, Newcomb J, Serafino R, Strathdee CA, Turci SM, Wilson C, DiMauro EF.. (2013) Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors., 56 (11): [PMID:23701517 ] [10.1021/jm4000038 ]